Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 307

1.
2.

Implantation of VVI pacemaker in a patient with dextrocardia, persistent left superior vena cava, and sick sinus syndrome: A case report.

Guo G, Yang L, Wu J, Sun L.

Medicine (Baltimore). 2017 Feb;96(5):e6028. doi: 10.1097/MD.0000000000006028.

3.

Risk factors for cardiac events in patients with Brugada syndrome: A PRISMA-compliant meta-analysis and systematic review.

Wu W, Tian L, Ke J, Sun Y, Wu R, Zhu J, Ke Q.

Medicine (Baltimore). 2016 Jul;95(30):e4214. doi: 10.1097/MD.0000000000004214. Review.

4.

A case report of QT prolongation with glycopyrronium bromide in a patient with chronic tamoxifen use.

Chiu MH, Al-Majed NS, Stubbins R, Pollmann D, Sandhu RK.

BMC Res Notes. 2016 Jun 14;9:310. doi: 10.1186/s13104-016-2105-4.

5.

Gene-Specific Therapy With Mexiletine Reduces Arrhythmic Events in Patients With Long QT Syndrome Type 3.

Mazzanti A, Maragna R, Faragli A, Monteforte N, Bloise R, Memmi M, Novelli V, Baiardi P, Bagnardi V, Etheridge SP, Napolitano C, Priori SG.

J Am Coll Cardiol. 2016 Mar 8;67(9):1053-8. doi: 10.1016/j.jacc.2015.12.033.

6.

Regional Implementation of a Pediatric Cardiology Syncope Algorithm Using Standardized Clinical Assessment and Management Plans (SCAMPS) Methodology.

Paris Y, Toro-Salazar OH, Gauthier NS, Rotondo KM, Arnold L, Hamershock R, Saudek DE, Fulton DR, Renaud A, Alexander ME; New England Congenital Cardiology Association (NECCA)..

J Am Heart Assoc. 2016 Feb 19;5(2). pii: e002931. doi: 10.1161/JAHA.115.002931.

7.

Screening and managing obstructive sleep apnoea in nocturnal heart block patients: an observational study.

Wu X, Liu Z, Chang SC, Fu C, Li W, Jiang H, Jiang L, Li S.

Respir Res. 2016 Feb 16;17:16. doi: 10.1186/s12931-016-0333-8.

8.

A novel mutation in the SCN5A gene contributes to arrhythmogenic characteristics of early repolarization syndrome.

Guo Q, Ren L, Chen X, Hou C, Chu J, Pu J, Zhang S.

Int J Mol Med. 2016 Mar;37(3):727-33. doi: 10.3892/ijmm.2016.2468.

9.

Presence or Absence of QTc Prolongation in Buprenorphine-Naloxone Among Youth With Opioid Dependence.

Poole SA, Pecoraro A, Subramaniam G, Woody G, Vetter VL.

J Addict Med. 2016 Jan-Feb;10(1):26-33. doi: 10.1097/ADM.0000000000000176.

10.

Myocardial infarction, symptomatic third degree atrioventricular block and pulmonary embolism caused by thalidomide: a case report.

Zhang S, Yang J, Jin X, Zhang S.

BMC Cardiovasc Disord. 2015 Dec 18;15:173. doi: 10.1186/s12872-015-0164-4.

11.

Case of Vasovagal Syncope With Asystole Associated With Propofol Sedation.

Fujii-Abe K, Uriu K, Kawahara H.

Anesth Prog. 2015 Winter;62(4):159-61. doi: 10.2344/13-00034.1.

12.

Impact of Cardiogenic Vomiting in Patients with STEMI: A Study From China.

Guo Z, Yang X, Chen M, Liu J, Xu L, Zhang Y.

Med Sci Monit. 2015 Dec 5;21:3792-7.

13.

Congestive Heart Failure Leads to Prolongation of the PR Interval and Atrioventricular Junction Enlargement and Ion Channel Remodelling in the Rabbit.

Nikolaidou T, Cai XJ, Stephenson RS, Yanni J, Lowe T, Atkinson AJ, Jones CB, Sardar R, Corno AF, Dobrzynski H, Withers PJ, Jarvis JC, Hart G, Boyett MR.

PLoS One. 2015 Oct 28;10(10):e0141452. doi: 10.1371/journal.pone.0141452.

14.

A clinical risk score of myocardial fibrosis predicts adverse outcomes in aortic stenosis.

Chin CW, Messika-Zeitoun D, Shah AS, Lefevre G, Bailleul S, Yeung EN, Koo M, Mirsadraee S, Mathieu T, Semple SI, Mills NL, Vahanian A, Newby DE, Dweck MR.

Eur Heart J. 2016 Feb 21;37(8):713-23. doi: 10.1093/eurheartj/ehv525.

15.

Arrhythmogenic Phenotype in Dilated Cardiomyopathy: Natural History and Predictors of Life-Threatening Arrhythmias.

Spezzacatene A, Sinagra G, Merlo M, Barbati G, Graw SL, Brun F, Slavov D, Di Lenarda A, Salcedo EE, Towbin JA, Saffitz JE, Marcus FI, Zareba W, Taylor MR, Mestroni L; Familial Cardiomyopathy Registry..

J Am Heart Assoc. 2015 Oct 16;4(10):e002149. doi: 10.1161/JAHA.115.002149.

16.

Right Atrial Myxoma and Syncope.

Babs Animashaun I, Akinseye OA, Akinseye LI, Akinboboye OO.

Am J Case Rep. 2015 Sep 21;16:645-7. doi: 10.12659/AJCR.894513.

17.

Long QT syndrome: how effective therapy in a single patient favorably influenced the long-term clinical course and genetic understanding of this hereditary disorder.

Lowengrub KM, Moss DR, Moss DA, Moss AJ.

Prog Cardiovasc Dis. 2015 Sep-Oct;58(2):221-6. doi: 10.1016/j.pcad.2015.08.002.

18.

Pharmacological treatment of acquired QT prolongation and torsades de pointes.

Thomas SH, Behr ER.

Br J Clin Pharmacol. 2016 Mar;81(3):420-7. doi: 10.1111/bcp.12726. Review.

19.

Heart rate variability and arrhythmic patterns of 24-hour Holter electrocardiography among Nigerians with cardiovascular diseases.

Adebayo RA, Ikwu AN, Balogun MO, Akintomide AO, Ajayi OE, Adeyeye VO, Mene-Afejuku TO, Bamikole OJ, Ogunyemi SA, Ajibare AO, Oketona OA.

Vasc Health Risk Manag. 2015 Jun 29;11:353-9. doi: 10.2147/VHRM.S81106.

20.

The Diagnosis, Risk Stratification, and Treatment of Brugada Syndrome.

Steinfurt J, Biermann J, Bode C, Odening KE.

Dtsch Arztebl Int. 2015 Jun 5;112(23):394-401. doi: 10.3238/arztebl.2015.0394. Review.

Supplemental Content

Loading ...
Support Center